Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:47 pm Sale | 13G | KEZAR LIFE SCIENCES INC KZR | ORBIMED ADVISORS LLC | 1,927,000 2.7% | -1,568,122 (-44.87%) | View |
| 2024-02-14 6:42 pm Purchase | 13G | Elevation Oncology Inc. ELEV | ORBIMED ADVISORS LLC | 3,000,000 6.8% | 3,000,000 (New Position) | View |
| 2024-02-14 6:36 pm Sale | 13G | Crinetics Pharmaceuticals Inc. CRNX | ORBIMED ADVISORS LLC | 1,667,360 2.5% | -1,529,516 (-47.84%) | View |
| 2024-02-14 6:30 pm Sale | 13G | Applied Therapeutics Inc. APLT | ORBIMED ADVISORS LLC | 0 0% | -7,300,921 (Position Closed) | View |
| 2024-02-05 4:48 pm Unchanged | 13D | CalciMedica Inc. CALC | ORBIMED ADVISORS LLC | 297,380 2.9% | 0 (Unchanged) | View |
| 2024-02-05 4:42 pm Purchase | 13D | ArriVent BioPharma Inc. AVBP | ORBIMED ADVISORS LLC | 3,027,328 9.1% | 3,027,328 (New Position) | View |
| 2024-01-29 4:55 pm Purchase | 13D | ADICET BIO INC ACET | ORBIMED ADVISORS LLC | 9,772,598 12.9% | 3,125,000 (+47.01%) | View |
| 2024-01-25 4:25 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 17.3% | 454,545 (+3.18%) | View |
| 2023-12-29 4:16 pm Sale | 13D | ALPINE IMMUNE SCIENCES INC. ALPN | ORBIMED ADVISORS LLC | 2,680,496 4.6% | -1,546,347 (-36.58%) | View |
| 2023-12-27 4:43 pm Unchanged | 13D | Theseus Pharmaceuticals Inc. THRX | ORBIMED ADVISORS LLC | 17,713,600 40.1% | 0 (Unchanged) | View |
| 2023-12-15 4:48 pm Sale | 13D | Disc Medicine Inc. IRON | ORBIMED ADVISORS LLC | 1,702,237 7.1% | -567,400 (-25.00%) | View |
| 2023-12-13 5:20 pm Unchanged | 13D | Keros Therapeutics Inc. KROS | ORBIMED ADVISORS LLC | 1,268,734 4.2% | 0 (Unchanged) | View |
| 2023-12-06 4:43 pm Sale | 13D | SpringWorks Therapeutics Inc. SWTX | ORBIMED ADVISORS LLC | 3,567,159 4.9% | -611,429 (-14.63%) | View |
| 2023-11-29 4:20 pm Sale | 13D | Apollomics Inc. APLM | ORBIMED ADVISORS LLC | 8,615,456 9.6% | -917,702 (-9.63%) | View |
| 2023-11-24 4:28 pm Unchanged | 13D | Theseus Pharmaceuticals Inc. THRX | ORBIMED ADVISORS LLC | 17,713,600 40.1% | 0 (Unchanged) | View |
| 2023-11-20 4:21 pm Sale | 13D | Apollomics Inc. APLM | ORBIMED ADVISORS LLC | 9,533,158 18.1% | -6,700,000 (-41.27%) | View |
| 2023-11-17 08:27 am Unchanged | 13D | Kinnate Biopharma Inc. KNTE | ORBIMED ADVISORS LLC | 7,559,729 16% | 0 (Unchanged) | View |
| 2023-11-14 4:57 pm Unchanged | 13D | Kinnate Biopharma Inc. KNTE | ORBIMED ADVISORS LLC | 7,559,729 16% | 0 (Unchanged) | View |
| 2023-11-13 08:51 am Purchase | 13D | ALPINE IMMUNE SCIENCES INC. ALPN | ORBIMED ADVISORS LLC | 4,226,843 7.3% | 145,251 (+3.56%) | View |
| 2023-11-01 5:08 pm Sale | 13D | Apollomics Inc. APLM | ORBIMED ADVISORS LLC | 16,233,158 18.1% | -1,810,477 (-10.03%) | View |